Identification and characterization of novel variants of the thioredoxin reductase 3 new transcript 1 TXNRD3NT1

Mammalian Genome

Volumn 16, Issue 1, 2005, Pages 41-49

  Matsuzaka, Yasunari ^a   Okamoto, Koichi ^a,b   Mabuchi, Tomotaka ^a   Iizuka, Mariko ^a   Ozawa, Akira ^a   Oka, Akira ^a   Tamiya, Gen ^a   Kulski, Jerzy K ^a,c   Inoko, Hidetoshi ^a  

^a TOKAI UNIVERSITY   (Japan)

^b CHUGAI PHARMACEUTICAL CO LTD   (Japan)

^c MURDOCH UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; BETA TUBULIN; COMPLEMENTARY DNA; MESSENGER RNA; NUCLEOTIDE; PRIMER DNA; THIOREDOXIN REDUCTASE; THIOREDOXIN REDUCTASE 3; THYMOCYTE ANTIBODY; UNCLASSIFIED DRUG;

3' UNTRANSLATED REGION; ARTICLE; AUTOREGULATION; BONE MARROW; CHROMOSOME 3Q; CODON; CONTROLLED STUDY; DNA ISOLATION; DNA MICROARRAY; DNA SEQUENCE; DOWN REGULATION; ESOPHAGUS; EXON; GENE AMPLIFICATION; GENE CONTROL; GENE EXPRESSION; GENE IDENTIFICATION; GENE LIBRARY; GENE MAPPING; GENETIC CODE; GENETIC SCREENING; GENETIC TRAIT; GENETIC TRANSCRIPTION; GENETIC VARIABILITY; GENOME; HUMAN; HUMAN CELL; KERATINOCYTE; MICROSATELLITE MARKER; MOLECULAR CLONING; NUCLEOTIDE SEQUENCE; OPEN READING FRAME; PANCREAS; PSORIASIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL DETECTION; TRANSLATION INITIATION;

ALTERNATIVE SPLICING; AMINO ACID SEQUENCE; BASE SEQUENCE; CHROMOSOME MAPPING; CHROMOSOMES, HUMAN, PAIR 3; EXONS; HUMANS; INTRONS; MOLECULAR SEQUENCE DATA; POLYMORPHISM, GENETIC; PSORIASIS; THIOREDOXIN REDUCTASE (NADPH); TRANSCRIPTION, GENETIC; VARIATION (GENETICS);

OTHER SEQUENCES;

EID: 13244273549     PISSN: 09388990     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00335-004-2416-y     Document Type: Article

References (36)

1. Altschul SF, Gish W, Miller W, Myers EW, Lipman DJ (1990) Basic local alignment search tool. J Mol Biol 215, 403-410
2. Bannister AJ, Cook A, Kouzarides T (1991) In vitro DNA binding activity of Fos/Jun and BZLF1 but not C/EBP is affected by redox changes. Oncogene 6(7), 1243-1250
3. Biguet C, Wakasugi N, Mishal Z, Holmgren A, Chouaib S, et al. (1994) Thioredoxin increases the proliferation of human B-cell lines through a protein kinase C-dependent mechanism. J Biol Chem 269(46), 28865-28870
4. Champliaud MF, Viel A, Baden HP (2003) The expression of vitamin D-upregulated protein 1 in skin and its interaction with sciellin in cultured keratinocytes. J Invest Dermatol 121(4), 781-785
5. Cromlish JA, Roeder RG (1989) Human transcription factor IIIC (TFIIIC). Purification, polypeptide structure, and the involvement of thiol groups in specific DNA binding. J Biol Chem 264(30), 18100-18109
6. Didier C, Kerblat I, Drouet C, Favier A, Beani J-C, et al. (2001) Induction of thioredoxin by ultraviolet-A radiation prevents oxidative-mediated cell death in human fibroblasts. Free Rad Biol Med 31, 585-598
7. Enlund F, Samuelsson L, Enerback C, Inerot A, Wahlstrom J, et al. (1999) Psoriasis susceptibility locus in chromosome region 3q21 identified in patients from southwest Sweden. Eur J Hum Genet 7, 783-790
8. Ericson ML, Horling J, Wendel-Hansen V, Holmgren A, Rosen A (1992) Secretion of thioredoxin after in vitro activation of human B cells. Lymphokine Cytokine Res 11(5), 201-207
9. Gasdaska PY, Gasdaska JR, Cochran S, Powis G (1995) Cloning and sequencing of a human thioredoxin reductase. FEES Lett 373(1), 5-9
10. Hayashi S, Hajiro-Nakanishi K, Makino Y, Eguchi H, Yodoi J, et al. (1997) Functional modulation of estrogen receptor by redox state with reference to thioredoxin as a mediator. Nucleic Acids Res 25(20), 4035-4040
11. Henseler T (1998) Genetics of psoriasis. Arch Dermatol Res 290, 4463-4476
12. Hewett D, Samuelsson L, Folding J, Enlund F, Smart D, et al. (2002) Identification of a psoriasis susceptibility candidate gene by linkage disequilibrium mapping with a localized single nucleotide polymorphism map. Genomics 79(3), 305-314
13. Hirota K, Matsui M, Iwata S, Nishiyama A, Mori K, et al. (1997) AP-1 transcriptional activity is regulated by a direct association between thioredoxin and Ref-1. Proc Natl Acad Sci USA 94(8), 3633-3638
14. Hirota K, Nakamura H, Masutani H, Yodoi J (2002) Thioredoxin superfamily and thioredoxin-inducing agents. Ann NY Acad Sci 957, 189-199
15. Holmgren A (1985) Thioredoxin. Annu Rev Biochem 54, 237-271
16. Junn E, Ran SH, Im JY, Yang Y, Cho EW, et al. (2000) Vitamin D3 up-regulated protein 1 mediates oxidative stress via suppressing the thioredoxin function. J Immunol 164, 6287-6295
17. Laurent TC, Moore EC, Reichard P (1964) Enzymatic synthesis of deoxyribonucleotides. IV. Isolation and characterization of thioredoxin, the hydrogen donor from Escherichia coli B. J Biol Chem 239, 3436-3444
18. Matsuzaka Y, Makino S, Nakajima K, Tomizawa M, Oka A, et al. (2000) New polymorphic microsatellite markers in the human MHC class II region. Tissue Antigens 56, 492-500
19. Matsuzaka Y, Okamoto K, Tsuji H, Mabuchi T, Ozawa A, et al. (2002) Identification of the hRDH-E2 gene, a novel member of the SDR family, and its increased expression in psoriatic lesion. Biochem Biophys Res Commun 297, 1171-1180
20. Matthews JR, Wakasugi N, Virelizier JL, Yodoi J, Hay RT (1992) Thioredoxin regulates the DNA binding activity of NF-kappa B by reduction of a disulphide bond involving cysteine 62. Nucleic Acids Res 20(15), 3821-3830
21. Nakamura H, Nakamura K, Yodoi J (1997) Redox regulation of cellular activation. Annu Rev Immunol 15, 351-369
22. Newman GW, Balcewicz-Sablinska MK, Guarnaccia JR, Remold HG, Silberstein DS (1994) Opposing regulatory effects of thioredoxin and eosinophil cytotoxicity-enhancing factor on the development of human immunodeficiency virus 1. J Exp Med 180(1), 359-363
23. Nishiyama A, Matsui M, Iwata S, Hirota K, Masutani H, et al. (1999) Identification of thioredoxin-binding protein-2/vitamin D(3) up-regulated protein 1 as a negative regulator of thioredoxin function and expression. J Biol Chem 274, 21645-21650
24. Oh JH, Chung AS, Steinbrenner H, Sies H, Brenneisen P (2004) Thioredoxin secreted upon ultraviolet A irradiation modulates activities of matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-2 in human dermal fibroblasts. Arch Biochem Biophys 423(1), 218-226
25. Oka A, Tamiya G, Tomizawa M, Ota M, Katsuyama Y, et al. (1999) Association analysis using refined microsatellite markers localizes a susceptibility locus for psoriasis vulgaris within a 111kb segment telomeric to the HLA-C gene. Hum Mol Genet 8, 2165-2170
26. Reichard P (1993) From RNA to DNA, why so many ribonucleotide reductases? Science 260, 1773-1777
27. Rubartelli A, Bajetto A, Allavena G, Wollman E, Sitia (1992) Secretion of thioredoxin by normal and neoplastic cells through a leaderless secretory pathway. J Biol Chem 267(34), 24161-24164
28. Saitoh M, Nishitoh H, Fujii M, Takeda K, Tobiume K, et al. (1998) Mammalian thioredoxin is a direct inhibitor of apoptosis signal-regulating kinase (ASK) 1. EMBO J 17(9), 2596-2606
29. Schallreuter KU, Wood JM (2001) Thioredoxin reductaser - its role in epidermal redox status. J Photochem Photobiol B 64, 179-184
30. Sun Q-A, Wu Y, Zappacosta F, Jeang K-T, Lee BJ, et al. (1999) Redox regulation of cell signaling by selenocysteine in mammalian thioredoxin reductases. J Biol Chem 247, 24522-24530
31. Tamura T, Stadtman TC (1996) A new selenoprotein from human lung adenocarcinoma cells: purification, properties, and thioredoxin reductase activity. Proc Natl Acad Sci USA 93(3), 1006-1011
32. Tanaka H, Makino Y, Okamoto K, Iida T, Yan K, et al. (1999) Redox regulation of the glucocorticoid receptor. Antioxid Redox Signal 1(4), 403-423
33. Toledano MB, Leonard WJ (1991) Modulation of transcription factor NF-kappa B binding activity by oxidation-reduction in vitro. Proc Natl Acad Sci USA. 88(10), 4328-4332
34. Tsuji H, Okamoto K, Matsuzaka Y, Iizuka H, Tamiya G, et al. (2003) SLURP-2, a novel member of the human Ly-6 superfamily that is up-regulated in psoriasis vulgaris. Genomics 81, 26-33
35. Wakasugi N, Tagaya Y, Wakasugi H, Mitsui A, Maeda M, et al. (1990) Adult T-cell leukemia-derived factor/thioredoxin, produced by both human T-lymphotropic virus type I- and Epstein-Barr virus-transformed lymphocytes, acts as an autocrine growth factor and synergizes with interleukin 1 and interleukin 2. Proc Natl Acad Sci USA 87(21), 8282-8286
36. Yen TJ, Machlin PS, Cleveland DW (1988) Autoregulated instability of beta-tubulin mRNAs by recognition of the nascent amino terminus of beta-tubulin. Nature 334, 580-585